Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer TherapyUfuk Degirmenci, Jiancheng Hu|Cells|2020Cited by 536
The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutantsJimin Yuan, Jiancheng Hu|Oncogene|2018Cited by 61
BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytesJiajun Yap, Jiancheng Hu|Molecular Cancer|2023Cited by 14
The Dimer-dependent Catalytic Activity of RAF Family Kinases Is Revealed Through Characterizing Their Oncogenic MutantsJimin Yuan, Jiancheng Hu|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 6
Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3 scaffoldXiaoyu Wan, Jiancheng Hu|Theranostics|2025Cited by 3